Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-(n-nitroso-n-methylamino)butyric Acid
2. Nitrosomethyl-3-carboxypropylamine
3. Nnmab
1. 61445-55-4
2. 4-[methyl(nitroso)amino]butanoic Acid
3. N-methyl-n-(3-carboxypropyl)nitrosamine
4. Nitrosomethyl-3-carboxypropylamine
5. 4-(n-nitroso-n-methylamino)butyric Acid
6. 4-(methylnitrosoamino)butanoic Acid
7. N-nitrosomethyl-3-carboxypropylamine
8. 7k7252tz54
9. Ccris 1123
10. 4-(methyl(nitroso)amino)butanoic Acid
11. Brn 2245230
12. N-nitroso-n-methyl-4-aminobutyricacid
13. Butanoic Acid,4-(methylnitrosoamino)-
14. Butyric Acid, 4-(methylnitrosoamino)-
15. N-nitrosomethylaminobutyric Acid
16. Dtxsid7040239
17. Schembl19463993
18. Unii-7k7252tz54
19. 4-(methylnitrosamino)butyric Acid
20. Chebi:176579
21. Nitroso-methyl-3-carboxypropylamine
22. Amy30252
23. Zinc5698935
24. Mfcd00869939
25. Akos006273157
26. As-63516
27. Nmba (losartan Potassium Impurity)
28. Ft-0672964
29. Ft-0672965
30. D93527
31. N-nitrosomethylaminobutyric Acid [usp-rs]
32. A937116
33. Methyl-n-(3-carboxypropyl)nitrosamine, N-
| Molecular Weight | 146.14 g/mol |
|---|---|
| Molecular Formula | C5H10N2O3 |
| XLogP3 | 0 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 4 |
| Exact Mass | 146.06914219 g/mol |
| Monoisotopic Mass | 146.06914219 g/mol |
| Topological Polar Surface Area | 70 Ų |
| Heavy Atom Count | 10 |
| Formal Charge | 0 |
| Complexity | 126 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
A N-Nitroso-N-Methyl-4-Aminobutyric Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of N-Nitroso-N-Methyl-4-Aminobutyric Acid, including repackagers and relabelers. The FDA regulates N-Nitroso-N-Methyl-4-Aminobutyric Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. N-Nitroso-N-Methyl-4-Aminobutyric Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A N-Nitroso-N-Methyl-4-Aminobutyric Acid supplier is an individual or a company that provides N-Nitroso-N-Methyl-4-Aminobutyric Acid active pharmaceutical ingredient (API) or N-Nitroso-N-Methyl-4-Aminobutyric Acid finished formulations upon request. The N-Nitroso-N-Methyl-4-Aminobutyric Acid suppliers may include N-Nitroso-N-Methyl-4-Aminobutyric Acid API manufacturers, exporters, distributors and traders.
N-Nitroso-N-Methyl-4-Aminobutyric Acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of N-Nitroso-N-Methyl-4-Aminobutyric Acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right N-Nitroso-N-Methyl-4-Aminobutyric Acid GMP manufacturer or N-Nitroso-N-Methyl-4-Aminobutyric Acid GMP API supplier for your needs.
A N-Nitroso-N-Methyl-4-Aminobutyric Acid CoA (Certificate of Analysis) is a formal document that attests to N-Nitroso-N-Methyl-4-Aminobutyric Acid's compliance with N-Nitroso-N-Methyl-4-Aminobutyric Acid specifications and serves as a tool for batch-level quality control.
N-Nitroso-N-Methyl-4-Aminobutyric Acid CoA mostly includes findings from lab analyses of a specific batch. For each N-Nitroso-N-Methyl-4-Aminobutyric Acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
N-Nitroso-N-Methyl-4-Aminobutyric Acid may be tested according to a variety of international standards, such as European Pharmacopoeia (N-Nitroso-N-Methyl-4-Aminobutyric Acid EP), N-Nitroso-N-Methyl-4-Aminobutyric Acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (N-Nitroso-N-Methyl-4-Aminobutyric Acid USP).
LOOKING FOR A SUPPLIER?
